PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1223501
PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1223501
Middle East and Africa colorectal cancer diagnostics market is projected to register a substantial CAGR of 6.9% from 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.
Middle East and Africa Colorectal Cancer Diagnostics Market, By Product Type (Instruments and Consumables & Accessories), Test Type (Stool Examination, Blood Test, Imaging Test, Tumor Markers, Biopsy, and Others), Stages (Stage 0, Stage I, Stage II, Stage III, and Stage IV), Cancer Type (Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors, and Others), Age Group (Geriatric, Adults, and Pediatric), End User (Hospital, Diagnostic Centers, Cancer Research Centers, Ambulatory Surgical Centers, Academic Institutes, and Others), Country (South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa) Industry Trends and Forecast to 2030.
Rise in healthcare expenditure for cancer diagnosis and treatment
Novel technological advancements in cancer diagnostics
Koninklijke Philips N.V.
Quest Diagnostics Incorporated
Bio-Rad Laboratories, Inc.
Merck KGaA
FUJIFILM Corporation
Agilent Technologies, Inc.
BD
General Electric Company
Siemens Healthcare GmbH
Abbott
Neusoft Corporation
BioFire Diagnostics
QIAGEN
Hologic, Inc.
PlexBio
GE HealthCare.